2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH)], uterine artery blood flow parameters[pulsation index (PI) and systolic/diastolic peak flow velocity at the end of the velocity ratio (S/D) and resistance index (RI)], levels of ovarian chocolate cyst markers[endometrial antibody (EMAb), matrix metalloproteinases-3 (MMP-3), prostaglandin F2 alpha (PGF2 alpha) and nuclear factor kappa B (nf-kappa B)] predominate, quality of life index (physical field, environment, social relationship and life grade) and 1 year recurrence rate were compared. Results After treatment, the clinical efficacy in the treatment group was significantly higher than the control group (P<0.05). After treatment, the levels of sex hormone indicators[estrogen 2 (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH)], uterine artery blood flow parameters[pulsation index (PI) and systolic/diastolic peak flow velocity at the end of the velocity ratio (S/D) and resistance index (RI)], levels of ovarian chocolate cyst markers[endometrial antibody (EMAb), matrix metalloproteinases-3 (MMP-3), prostaglandin F2 alpha (PGF2 alpha) and nuclear factor kappa B (nf-kappa B)] predominate, quality of life index (physical field, environment, social relationship and life grade) in the 2 groups were significantly promoted (P<0.05), while the treatment group were significantly improved than those in the control group (P<0.05). Follow up for 1 year, the recurrence rates in the treatment group was significantly lower than the control group (P<0.05).Conclusion Xiaojin Capsules combined with Leuprorelin Acetate Microspheres for Injection in treatment of ovarian chocolate cyst has significant clinical effect in treatment of ovarian chocolate cyst, which has a certain clinical application value."/>